Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
- PMID: 37892134
- PMCID: PMC10604481
- DOI: 10.3390/biom13101452
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
Abstract
In light of the COVID-19 global pandemic caused by SARS-CoV-2, ongoing research has centered on minimizing viral spread either by stopping viral entry or inhibiting viral replication. Repurposing antiviral drugs, typically nucleoside analogs, has proven successful at inhibiting virus replication. This review summarizes current information regarding coronavirus classification and characterization and presents the broad clinical consequences of SARS-CoV-2 activation of the angiotensin-converting enzyme 2 (ACE2) receptor expressed in different human cell types. It provides publicly available knowledge on the chemical nature of proposed therapeutics and their target biomolecules to assist in the identification of potentially new drugs for the treatment of SARS-CoV-2 infection.
Keywords: ACE2; COVID-19; coronavirus; drug design; nucleoside analogs; target cell responses.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
In silico screening of FDA approved drugs against ACE2 receptor: potential therapeutics to inhibit the entry of SARS-CoV-2 to human cells.J Biomol Struct Dyn. 2022;40(21):11383-11394. doi: 10.1080/07391102.2021.1960892. Epub 2021 Aug 28. J Biomol Struct Dyn. 2022. PMID: 34455932
-
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20. mBio. 2020. PMID: 32913009 Free PMC article.
-
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):317-325. doi: 10.1093/ehjcvp/pvaa053. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32464637 Free PMC article. Review.
-
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10. J Pathol. 2020. PMID: 32418199 Free PMC article. Review.
-
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.Curr Top Med Chem. 2020;20(16):1423-1433. doi: 10.2174/1568026620999200517043137. Curr Top Med Chem. 2020. PMID: 32416679
References
-
- WHO. 2023. [(accessed on 18 September 2023)]. Available online: https://covid19.who.int/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous